Ticker Details
MIMEDX GROUP INC MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.
IPO Date:	March 1, 2008
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$765.69M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 2.45%
Avg Daily Range (30 D):	$0.08 | 1.52%
Avg Daily Range (90 D):	$0.12 | 1.81%

Institutional Daily Volume
Avg Daily Volume:	.77M
Avg Daily Volume (30 D):	.82M
Avg Daily Volume (90 D):	.75M

Trade Size
Avg Trade Size (Sh.):	144
Avg Trade Size (Sh.) (30 D):	92
Avg Trade Size (Sh.) (90 D):	88

Institutional Trades
Total Institutional Trades:	2,094
Avg Institutional Trade:	$1.39M
Avg Institutional Trade (30 D):	$.95M
Avg Institutional Trade (90 D):	$.94M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.47M
Avg Closing Trade (30 D):	$.77M
Avg Closing Trade (90 D):	$.91M
Avg Closing Volume:	175.47K

News

Feb 17, 2026 @ 1:00 PM MIMEDX to Host Fourth Quarter and Full Year 2025 O... Source: Na

Feb 2, 2026 @ 1:00 PM MIMEDX Celebrates 15 Year Anniversary of EPIFIXÂÂ... Source: Mimedx Group, Inc.

Oct 15, 2025 @ 12:00 PM MIMEDX to Host Third Quarter 2025 Operating and Fi... Source: Matt Notarianni

Sep 3, 2025 @ 12:00 PM MIMEDX to Sponsor and Attend Symposium on Advanced... Source: Matt Notarianni

Feb 12, 2025 @ 12:00 PM MediWound Initiates the VALUE Global Phase III Piv... Source: N/A

Financials
	TTM	Q1 2025	Q4 2024
Basic EPS	$.07	$.05	$.05
Diluted EPS	$.06	$.05	$.05
Revenue	$98.61M	$88.21M	$92.91M
Gross Profit	$79.92M	$71.65M	$76M
Net Income / Loss	$9.62M	$7.02M	$7.44M
Operating Income / Loss	$12.37M	$8.25M	$11.05M
Cost of Revenue	$18.68M	$16.56M	$16.91M
Net Cash Flow	$12.44M	$2.02M	$15.62M
PE Ratio	90.83

Splits
Apr 02, 2008	11:34